The once-daily oral therapy is available in five strengths, with clinical studies showing reductions in seizure frequency among adults with uncontrolled focal seizures For the full story, visit the source.
Business
Alkem Laboratories launches NeuCeno for partial-onset seizures in adults
The once-daily oral therapy is available in five strengths, with clinical studies showing reductions in seizure frequency among adults with uncontrolled focal seizures
By PTI· BusinessLine· 18 days ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine